周二，伯恩斯坦兴业银行集团 (Bernstein SocGen Group)将默沙东 (Merck, NYSE:MRK)的目标股价从此前的$110下调至$95，同时维持"市场表现"评级。分析师Courtney Breen指出，默沙东的疫苗Gardasil即将失去专利独占权 ...

Shares of Merck & Co. Inc. fell more than 0.5% on Monday afternoon, tracking their fifth consecutive decline in the worst ...

In this piece, we will look at the stocks Jim Cramer recently discussed.

We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

Bernstein SocGen Group has revised its price target for Merck (NYSE:MRK) shares, bringing it down to $95 from the previous $110 while maintaining a Market Perform rating. Analyst Courtney Breen cited ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...